Hardy C L, Rolland J M, O'Hehir R E
Department of Allergy, Immunology & Respiratory Medicine, Monash University and The Alfred Hospital, Melbourne, Vic., Australia.
Department of Immunology, Monash University, Melbourne, Vic., 3004, Australia.
Clin Exp Allergy. 2015 Oct;45(10):1510-22. doi: 10.1111/cea.12561.
Activin A, a member of the TGF-β superfamily of cytokines, was originally identified as an inducer of follicle stimulating hormone release, but has since been ascribed roles in normal physiological processes, as an immunoregulatory cytokine and as a driver of fibrosis. In the last 10-15 years, it has also become abundantly clear that activin A plays an important role in the regulation of asthmatic inflammation and airway remodelling. This review provides a brief introduction to the activin A/TGF-β superfamily, focussing on the regulation of receptors and signalling pathways. We examine the contradictory evidence for generalized pro- vs. anti-inflammatory effects of activin A in inflammation, before appraising its role in asthmatic inflammation and airway remodelling specifically by evaluating data from both murine models and clinical studies. We identify key issues to be addressed, paving the way for safe exploitation of modulation of activin A function for treatment of allergic asthma and other inflammatory lung diseases.
激活素A是细胞因子TGF-β超家族的成员,最初被鉴定为促卵泡激素释放的诱导剂,但此后被认为在正常生理过程中发挥作用,作为一种免疫调节细胞因子和纤维化的驱动因子。在过去的10至15年中,激活素A在哮喘炎症和气道重塑的调节中发挥重要作用也变得越来越明显。本综述简要介绍了激活素A/TGF-β超家族,重点关注受体和信号通路的调节。在通过评估来自小鼠模型和临床研究的数据具体评估其在哮喘炎症和气道重塑中的作用之前,我们研究了激活素A在炎症中普遍存在的促炎与抗炎作用的矛盾证据。我们确定了需要解决的关键问题,为安全利用激活素A功能调节来治疗过敏性哮喘和其他炎症性肺病铺平道路。